CD38-NAD + Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response
Cell Metabolism - United States
doi 10.1016/j.cmet.2017.10.006
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2018
Authors
Publisher
Elsevier BV
Available in full text
January 1, 2018
Elsevier BV